Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2025-12-24 @ 10:15 PM
NCT ID:
NCT03621735
Eligibility Criteria:
Inclusion Criteria:
* Must report constant, subjective, preferably unilateral tinnitus without any active external or middle ear pathology.
* No greater than a mild hearing loss up to 6 kHz, and no greater than a moderate hearing loss at the tinnitus frequencies.
* Must be able to modulate their tinnitus with a somatic maneuver
* Preferably onset of tinnitus less than one year ago, but present for at least 6 months. Tinnitus should be bothersome.
* Absence of retrocochlear pathology/8th nerve lesion
* No participation in a tinnitus treatment regimen within the past six months or participation in the University of Michigan stage 1 clinical trial.
Exclusion Criteria:
* Diagnosis of Meniere's disease
* Diagnosis of Semicircular Canal Dehiscence
* Unilateral or bilateral cochlear implant recipients
* Diagnosis of acoustic neuroma
* Evidence of retrocochlear disease
* Certain medications and conditions (will be reviewed at screening)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03621735
Study Brief:
Protocol Section:
NCT03621735